Real-World Treatment Patterns and Patient reported outcome in COPD (REMIND) - REMIND

Study identifier:D5980R00080

ClinicalTrials.gov identifier:NCT05903989

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A secondary database study using COPD cohort study in Japan to investigate health status of COPD patients with different inhaler treatment

Medical condition

COPD

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

708

Study type

Observational

Age

n/a - n/a

Date

Study Start Date: 11 Sept 2023
Primary Completion Date: 24 Oct 2023
Study Completion Date: 24 Oct 2023

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 May 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria